- Home
- NVAX vs WABC Comparison
NVAX vs WABC Comparison
Compare NVAX & WABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- WABC
- Stock Information
- Founded
- NVAX 1987
- WABC 1972
- Country
- NVAX United States
- WABC United States
- Employees
- NVAX N/A
- WABC N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- WABC Major Banks
- Sector
- NVAX Health Care
- WABC Finance
- Exchange
- NVAX Nasdaq
- WABC Nasdaq
- Market Cap
- NVAX 1.3B
- WABC 1.2B
- IPO Year
- NVAX 1995
- WABC N/A
- Fundamental
- Price
- NVAX $6.47
- WABC $46.17
- Analyst Decision
- NVAX Buy
- WABC Hold
- Analyst Count
- NVAX 5
- WABC 3
- Target Price
- NVAX $16.60
- WABC $52.50
- AVG Volume (30 Days)
- NVAX 6.2M
- WABC 118.4K
- Earning Date
- NVAX 08-07-2025
- WABC 07-17-2025
- Dividend Yield
- NVAX N/A
- WABC 3.98%
- EPS Growth
- NVAX N/A
- WABC N/A
- EPS
- NVAX 2.97
- WABC 4.99
- Revenue
- NVAX $1,254,962,000.00
- WABC $284,570,000.00
- Revenue This Year
- NVAX $56.85
- WABC N/A
- Revenue Next Year
- NVAX N/A
- WABC N/A
- P/E Ratio
- NVAX $2.17
- WABC $9.26
- Revenue Growth
- NVAX 25.92
- WABC N/A
- 52 Week Low
- NVAX $5.01
- WABC $42.00
- 52 Week High
- NVAX $17.81
- WABC $59.97
- Technical
- Relative Strength Index (RSI)
- NVAX 39.95
- WABC 36.62
- Support Level
- NVAX $6.26
- WABC $45.33
- Resistance Level
- NVAX $7.80
- WABC $47.40
- Average True Range (ATR)
- NVAX 0.36
- WABC 0.98
- MACD
- NVAX -0.13
- WABC -0.26
- Stochastic Oscillator
- NVAX 1.62
- WABC 20.00
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About WABC Westamerica Bancorporation
Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California and all the way east to Nevada County.